This part of GB/T 16886 specifies strategies and tests for the identification of medical device hazards for the following biological aspects: — genotoxicity, carcinogenicity, and — reproductive and developmental toxicity. This part of GB/T 16886 applies to the evaluation of medical devices that are identified as having potential genotoxicity, carcinogenicity or reproductive toxicity.
GB/T 16886.3-2008 Referenced Document
GB/T 16886.1 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process*, 2022-04-15 Update
GB/T 16886.12 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials*, 2023-11-27 Update
GB/T 16886.2 Biological evaluation of medical devices.Part 2: Animal welfare requirements *, 2011-12-30 Update
GB/T 16886.6 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation*, 2022-04-15 Update
GB/T 16886.3-2008 history
2019GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
2008GB/T 16886.3-2008 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
1997GB/T 16886.3-1997 Biological evaluation of medical devices--Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity